Previous Close | 0.0149 |
Open | 0.0145 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0145 - 0.0152 |
52 Week Range | 0.0100 - 0.0400 |
Volume | |
Avg. Volume | 4,650,345 |
Market Cap | 55.365M |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | 7.40 |
EPS (TTM) | 0.0020 |
Earnings Date | Aug 15, 2022 - Aug 19, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MJNA
SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its pharmaceutical subsidiary, HM Pharma, has submitted a product dossier for its cannabidiol (CBD) products after receiving Sanitary Authorization from ANVISA, Brazil’s Health Regulatory Ag
ESTERO, Fla., Aug. 05, 2022 (GLOBE NEWSWIRE) -- GRN Holdings Corporation, Inc. (OTC Pink: GRNF) announces a change in management, its business model and a corporate restructuring. One of the first steps in support of the Company’s new direction will be to file amended articles with the Secretary of State of Delaware and a related FINRA corporate action to change the Company’s name to Marijuana Inc. In addition to changing the Company’s corporate name to Marijuana Inc., the Company announces the
SAN DIEGO, CA, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its CEO Blake Schroeder has published an article in Nasdaq News to provide the industry with insight on the future of federal cannabis legalization in the U.S. In his article titled, “​